By Blandine Lacroix, Petra Molan, and Dan Schell
In recent years we’ve seen more and more companies stressing the need for better diversity and inclusion (D&I) in life sciences. That not surprising, considering the lack of D&I in this industry has been a longstanding and well-known issue. It’s also an issue that has multiple facets. For example, sometimes these discussions are focused on the lack of D&I in clinical trials and how that can negatively affect overall therapeutic outcomes. Then there’s the concern over the lack of D&I among boards or leadership in general. And finally, there’s the need for a more diverse and inclusive workforce, and how such a composition can lead to more business success.
Search our website and you’ll find multiple articles, podcasts, and executive virtual roundtables (video) related to the various aspects of D&I. Much of that content includes tangible ways you can improve D&I in your organization. In the following, we present two first-hand accounts of what it has been like to be a woman working in the pharma industry for many years, and what we can do to overcome this industrywide challenge and continue to push us forward.